{"product_id":"hfsa-board-certification-review","title":"HFSA Board Certification Review 2021","description":"\u003cdiv class=\"celwidget\" data-cel-widget=\"bookDescription_feature_div\" data-csa-c-asin=\"\" data-csa-c-content-id=\"bookDescription\" data-csa-c-id=\"sp3pi4-mkskqy-y4o8kl-7jkh2a\" data-csa-c-is-in-initial-active-row=\"false\" data-csa-c-slot-id=\"bookDescription_feature_div\" data-csa-c-type=\"widget\" data-feature-name=\"bookDescription\" id=\"bookDescription_feature_div\"\u003e\n\u003cdiv class=\"a-expander-collapsed-height a-row a-expander-container a-spacing-base a-expander-partial-collapse-container\" data-a-expander-collapsed-height=\"140\" data-a-expander-name=\"book_description_expander\"\u003e\n\u003cdiv aria-expanded=\"false\" class=\"a-expander-content a-expander-partial-collapse-content\"\u003e\n\u003cdiv class=\"toc-header bottomShadow topPadding\" id=\"toc-header\"\u003e\n\u003cdiv class=\"mura-body\"\u003e\n\u003cdiv class=\"mura-region mura-region-loose\"\u003e\n\u003cdiv class=\"mura-region-local\"\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv class=\"panel entry-content active\" id=\"tab-description\"\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv class=\"panel entry-content active\" id=\"tab-description\"\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003cdiv class=\"prod-format\"\u003e\n\u003ch1\u003eHFSA Board Certification Review 2021\u003c\/h1\u003e\n\u003ch3\u003e\n\u003cstrong\u003eMp4 lectures \u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003ePDF study materials\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eQuestions bank\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cstrong\u003eHeart Failure Fundamentals (Pre-Recorded)\u003c\/strong\u003eHeart Failure Epidemiology and Risk Factors\u003cstrong\u003eSadiya Khan\u003c\/strong\u003ePathophysiology I: Cellular and Energetic Considerations\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eDaniel Burkhoff\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003ePathophysiology II: Hemodynamic, Structural, and Neurohormonal Considerations\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eDaniel Burkhoff\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDiagnosis and Clinical Assessment\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eMark Drazner\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCardio-Oncology for the HF boards\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eBonnie Ky\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eClinico-Pathologic Correlates in Heart Failure\/ Images for the Heart Failure Boards\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eJon Lomasney\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eStatistics for the HF Board\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eBrian Claggett\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eCardiac Transplantation\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAdvanced Heart Failure: Defining the Phenotype and Patient Selection for Advanced Therapies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eNancy Sweitzer\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003elmmunology: The Basics, PRA, Sensitization, Crossmatch\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eSean Pinney\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eRejection: Cellular and Antibody Mediated\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eSean Pinney\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eManaging Immunosuppression and Drugs\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eMichelle Kittleson\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eHeart Transplant, Clinical Outcomes and Complications\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eMichelle Kittleson\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eQ\u0026amp;A Panel I\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eAkshay Desai, Nancy Sweitzer, Jonathan Rich, Maria Rosa\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eKey Issues in HF Management\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eHemodynamics in HF I\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eJames Fang\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eHemodynamics in HF II\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eJames Fang\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDrug Therapy for Chronic HF I: Focus on established therapies (ACE\/ARB\/Beta-blocker\/MRA\/Digoxin\/Hydralazine+Nitrates)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eClyde Yancy\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDrug Therapy for Chronic HF II: Focus on newer therapies (Sacubitril\/Valsartan, Ivabradine, SGLT2 inhibitors)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eMark Drazner\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eHFpEF: Epidemiology, Risk Factors, Diagnosis, Management (for the boards)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eSanjiv Shah\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003ePulmonary Hypertension\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eJonathan Rich\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eManagement of Common Arrhythmias I – Atrial Fib and Flutter\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eRoderick Tung\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eManagement of Common Arrhythmias in HF II\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eRoderick Tung\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDevice Therapy in Heart Failure I – Sudden Death Prevention\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eWendy Tzou\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDevice Therapy in Heart Failure II – CRT\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eWendy Tzou\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eManagement of the Hospitalized HF Patient\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eMaria Rosa Costanzo\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCardio Renal Failure Interactions in Heart Failure\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eJeff Testani\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eSpecific Heart Failure Syndromes\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eSpecific Etiologies of HF I: Common Etiologies (CAD, ETOH, Peripartum, Myocarditis)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eAkshay Desai\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eSpecific Etiologies of HF II: Inherited HF syndromes (including HCM, ARVC, and LVNC)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eJane Wilcox\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eSpecific Etiologies of HF III: Infiltrative Disorders and Restrictive Cardiomyopathy (Amyloidosis, Sarcoidosis, Hemochromatosis, Fabry)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eSanjiv Shah\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eQ\u0026amp;A Panel II\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eAkshay Desai, Nancy Sweitzer, Jonathan Rich, Maria Rosa\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eGuest: James Fang\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eShock\/MCS\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eCardiogenic Shock Management\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eNancy Sweitzer\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eMCS I: Durable MCS Devices and Outcomes\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eJoseph Rogers\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eMCS II: Temporary Support Devices and ECMO for the Boards\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eJennifer Cowger\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eMCS III: MCS Complications and Patient Management\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eJennifer Cowger\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eMCS IV: Interactive Shock and Device Management\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eDaniel Burkhoff, Jennifer Cowger, Joseph Rogers, Nancy Sweitzer\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eSpecial Topics in HF\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAssessment of Functional Capacity including cardiopulmonary exercise testing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eGregory Lewis\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAdult Congenital Heart Disease for the HF Specialist\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eEric Krieger\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eIssues in Chronic HF Disease Management (Biomarkers, Remote Monitoring, Lifestyle Interventions)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eAkshay Desai\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eManagement of Valvular Heart Disease in Heart Failure (including functional MR, low gradient AS, tricuspid regurgitation)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eJane Wilcox\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eManagement of Comorbidities in Heart Failure – Diabetes, Sleep Disorders, Iron Deficiency\/Anemia, COPD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eMaria Rosa Costanzo\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eQ\u0026amp;A Panel III\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003eAkshay Desai, Nancy Sweitzer, Jonathan Rich\u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv aria-expanded=\"false\" class=\"a-expander-content a-expander-partial-collapse-content\"\u003e\n\u003cdiv class=\"toc-header bottomShadow topPadding\" id=\"toc-header\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954292691042,"sku":"MED-AMB00455","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/HFSA-Board-Certification-Review-2021.jpg?v=1779370271","url":"https:\/\/meducourse.com\/products\/hfsa-board-certification-review","provider":"Meducourse","version":"1.0","type":"link"}